A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients.
about
Co- and Post-Translational Protein Folding in the ERThe signal peptide of the IgE receptor alpha-chain prevents surface expression of an immunoreceptor tyrosine-based activation motif-free receptor pool.LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility.Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome.GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients.Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation.LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment.A new LH receptor splice mutation responsible for male hypogonadism with subnormal sperm production in the propositus, and infertility with regular cycles in an affected sister.Phenotypic and pharmacogenetic aspects of ovulation induction in WHO II anovulatory women.Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic rolesPolymorphism in the Alternative Donor Site of the Cryptic Exon of LHCGR: Functional Consequences and Associations with Testosterone Level.Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.Protein folding in the endoplasmic reticulumAssociation of the luteinizing hormone/choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome.Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women.Human Chorionic Gonadotropin and Breast CancerThe 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population.
P2860
Q28078736-9B338126-B689-4CB0-8377-5A2C8D66C8D9Q33832396-D6B5DF1F-754C-4905-8BD8-281A808B43DAQ35816229-D809B0B6-47E7-4DEE-BD28-228259462C95Q36112579-7C3E9362-0559-4B06-86E3-085478375E08Q36393294-5D719855-274E-46D1-9572-56A996F1F628Q37056654-CD8A37AF-1D5A-40DD-9DEC-DE4C51A0C45FQ37218593-3F972009-C4BB-4E34-8ACE-0B7D93A225A5Q37323359-37C5FD68-04C9-4418-86B9-74120A04A39BQ37466378-6F1C3038-914C-4A7A-9D55-4D8EB0B8E3F1Q37641680-DCA2EB06-AB5B-4091-896B-A8AFB2DBE102Q37734658-EAB07011-43EE-4ABD-9882-6F897EC8AEE1Q37931055-7545F86F-2DE0-454F-84DC-F88682F349EEQ38103530-F935EFB7-CFD6-4892-B04D-0EF5491F73D8Q38895990-BF764637-AE09-4565-9F73-B28EC46A9FE3Q38989640-1EB67048-E3D0-4415-880B-4980AC3B655DQ41183501-58BAE408-219E-44B3-AB25-E0D2C4D6F807Q50962746-94E32396-EBDB-4818-B293-E9D737433025
P2860
A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A common polymorphism renders ...... ome in breast cancer patients.
@en
A common polymorphism renders ...... ome in breast cancer patients.
@nl
type
label
A common polymorphism renders ...... ome in breast cancer patients.
@en
A common polymorphism renders ...... ome in breast cancer patients.
@nl
prefLabel
A common polymorphism renders ...... ome in breast cancer patients.
@en
A common polymorphism renders ...... ome in breast cancer patients.
@nl
P2093
P356
P1476
A common polymorphism renders ...... come in breast cancer patients
@en
P2093
Andre G Uitterlinden
Axel P N Themmen
Djura Piersma
Els M J J Berns
Huibert A P Pols
Miriam Verhoef-Post
P304
P356
10.1210/JC.2005-2156
P407
P577
2006-02-07T00:00:00Z